Status:
COMPLETED
Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to identify, through the use of questionnaires, demographic, clinical and psychological factors that could better correlate with the satisfaction of psoriatic patients in systemic ther...
Detailed Description
Psoriasis is a chronic inflammatory disease with a significant impact on the quality of life of those affected. The introduction of monoclonal antibodies directed against key cytokines in the pathogen...
Eligibility Criteria
Inclusion
- Patients with age\>18 years, of both sexes;
- Diagnosis of plaque psoriasis, with or without concomitant arthritis
- Patients who have been receiving systemic biologics for at least one year and have disease severity (PASI) and quality of life (DLQI) data available at baseline (prior to initiation of treatment);
- Signature of the written informed consent;
Exclusion
- Presence of a psychiatric pathology already diagnosed
- Patients with psoriasis variants (pustular, guttate, palmoplantar)
Key Trial Info
Start Date :
September 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2024
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06102356
Start Date
September 13 2023
End Date
June 15 2024
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli
Rome, Lazio, Italy, 00168